BSE filing, NSE: HALEOSLABS. Summary written from the filing by ALFA Finder's alert engine.
Haleos Labs Ltd: key numbers
- Share price
- ₹1,450.60
- Market cap
- ₹438.6 Cr
- Revenue (annual)
- ₹333.8 Cr
- Net profit (annual)
- ₹17.31 Cr
- P/E (TTM)
- 27.8×Sector 46.1×
- Promoter holding
- 72.11%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Haleos Labs Ltd
All →Haleos Labs Annual General Meeting
Haleos Labs Limited conducted its 20th Annual General Meeting on September 30, 2026. The meeting discussed financial statements, dividend declaration, and various director reappointments.
Haleos Labs Business Update
USFDA inspected the material subsidiary Mahi Drugs' API facility in Parawada. The inspection concluded with zero Form 483 observations.
Haleos Labs Annual Report
Haleos Labs Ltd has submitted its Annual Report for the financial year 2025-26, along with the Notice for its 20th Annual General Meeting.
Haleos Labs Dividend
Haleos Labs Limited recommended a final dividend of ₹15 per equity share for FY 2025-26. The record date is fixed for September 23, 2026.
Haleos Labs Annual General Meeting
Haleos Labs Limited announced postal ballot results where shareholders approved director reappointment and related party transactions. However, a resolution for managerial remuneration was rejected by shareholders.
Haleos Labs Management Change
Haleos Labs Limited has re-appointed Dr. Mannam Malakondaiah and Dr. Srinivas Samavedam as Independent Directors for five-year terms starting November 13, 2026. Shareholder approval is required.
- Execution
- 5 years
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.